Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: Effect of growth hormone replacement therapy

Clinical Endocrinology

Volumn 63, Issue 5, 2005, Pages 537-542

  Mohn, Angelika ^a   Di Marzio, Daniele ^a   Giannini, Cosimo ^a   Capanna, Rita ^a   Marcovecchio, Maria ^a   Chiarelli, Francesco ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; GROWTH HORMONE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZING AGENT; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; EVALUATION; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; ITALY; MALE; OXIDATION; OXIDATIVE STRESS; PARAMETER; PREPUBERTY; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE; VITAMIN BLOOD LEVEL;

ANTIOXIDANTS; CASE-CONTROL STUDIES; CHILD; FEMALE; GROWTH DISORDERS; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; LIPOPROTEINS, LDL; MALE; MALONDIALDEHYDE; NUTRITIONAL STATUS; OXIDATION-REDUCTION; OXIDATIVE STRESS; RECOMBINANT PROTEINS; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; VITAMIN E;

EID: 27744435707     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02378.x     Document Type: Article

References (34)

1. Salomon, F., Cuneo, R.C., Hesp, R. & Sonksen, P.H. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
2. Johansson, J.O., Fowelin, J., Landin, K., Lager, I. & Bengtsson, B.A. (1995) Growth hormone-deficient adults are insulin-resistant. Metabolism, 44, 1126-1129.
3. Russell-Jones, D.L., Watts, G.F., Weissberger, A., Naoumova, R., Myers, J., Thompson, G.R. & Sonksen, P.H. (1994) The effect of GH replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult GHD patients. Clinical Endocrinology, 41, 345-350.
4. Chisolm, G.M. & Steinberg, D. (2000) The oxidative modification hypothesis of atherogenesis: an overview. Free Radical Biology and Medicine, 28, 1815-1826.
5. Iuliano, L. (2001) The oxidant stress hypothesis of atherogenesis. Lipids, 36, S41-S44.
6. Steinberg D., Witztum J.L. (2002) Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation, 105, 2107-2111.
7. Thomas, A.M. & Berglund, L. (2001) Growth hormone and cardiovascular disease: an area in rapid growth. Journal of Clinical Endocrinology and Metabolism, 86, 1871-1873.
8. Bates, A.S., Van't Hoff, W., Jones, P.J. & Clayton, R.N. (1996) The effect of hypopituitarism on life expectancy. Journal of Clinical Endocrinology and Metabolism, 81, 1169-1172.
9. Bulow, B., Hagmar, L., Mikoczy, Z., Nordstrom, C.H. & Erfurth, E.M. (1997) Increased cerebrovascular mortality in patients with hypopituitarism. Clinical Endocrinology, 46, 75-81.
10. Berenson, G.S., Srinivasan, S.R., Bao, W., Newman, W.P., Tracy, R.E. & Wattigney, W.A. (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. New England Journal of Medicine, 338, 1650-1656.
11. Chung, B.H., Segrest, J.P., Ray, M.J., Brunzell, J.D., Hokanson, J.E., Krauss, R.M., Beaudrie, K. & Cone, J.T. (1986) Single vertical spin density gradient ultracentrifugation. Methods in Enzymology, 128, 181-209.
12. Lynch, S.M. & Frei, B. (1993) Mechanisms of copper- and iron-dependent oxidative modification of human low-density lipoprotein. Journal of Lipid Research, 34, 1745-1753.
13. Lowry, O.H., Rosebrough, N.J., Farr, A.L. & Randall, R.J. (1951) Protein measurement with the Polin phenol reagent. Journal of Biological Chemistry, 193, 265-275.
14. Esterbauer, H., Striegl, G., Puhl, H. & Rotheneder, M. (1989) Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Research Communications, 6, 67-75.
15. Simon, B.C., Cunningham, L.D. & Cohen, R.A. (1990) Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. Journal of Clinical Investigation, 86, 75-79.
16. Lee, B.L., Chua, S.C., Ong, H.Y. & Ong, C.N. (1992) High performance liquid chromatographic method for routine determination of vitamins A and E and beta-carotene in plasma. Journal of Chromatography, 581, 41-47.
17. GH Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. Journal of Clinical Endocrinology and Metabolism, 85, 3990-3993.
18. Regal, M., Paramo, C., Sierra, J.M. & Garcia-Mayor, R.V. (2001) Prevalence and incidence of hypopituitarism in adult Caucasian population in northwestern Spain. Clinical Endocrinology, 55, 735-740.
19. Lindsay, R., Feldkamp, M., Harris, D., Robertson, J. & Rallison, M. (1994) Utah growth study: growth standards and prevalence of growth hormone deficiency. Journal of Pediatrics, 125, 29-35.
20. Capaldo, B., Patti, L., Oliviero, U., Longobardi, S., Pardo, F., Vitale, F., Fazio, S., Di Rella, F., Biondi, B., Longobardi, G. & Saccà, L. (1997) Increased arterial intima-media thickness in childhood-onset growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 82, 1378-1381.
21. Markussis, V., Beshyah, S.A., Fisher, C., Sharp, P., Nicolaides, A.N. & Johnston, D.G. (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet, 340, 1188-1192.
22. Pfeifer, M., Verhovec, R., Zizek, B., Prezelj, J., Poredos, P. & Clayton, R.N. (1999) Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. Journal of Clinical Endocrinology and Metabolism, 84, 453-457.
23. Stehbens, W.E. (1999) The oxidative stress hypothesis of atherosclerosis: cause or product? Medical Hypotheses, 53, 507-515.
24. Frei, B. (1995) Cardiovascular disease and nutrient antioxidants: role of low-density lipoprotein oxidation. Critical Reviews in Food Science and Nutrition, 35, 83-98.
25. Witztum, J.L. & Steinberg, D. (1991) Role of oxidized low density lipoprotein in atherogenesis. Journal of Clinical Investigation, 88, 1785-1792.
26. Mukai, EH. & Goldstein, B.D. (1976) Mutagenicity of malondialdehyde, a decomposition product of peroxidized polyunsaturated fatty acids. Science, 191, 868-869.
27. Evans, L.M., Davies, J.S., Goodfellow, J., Rees, J.A. & Scanlon, M.F. (1999) Endothelial dysfunction in hypopituitary adults with growth hormone deficiency. Clinical Endocrinology, 50, 457-464.
28. Evans, L.M., Davies, J.S., Anderson, R.A., Ellis, G.R., Jackson, S.K., Lewis, M.J., Frenneaux, M.P., Rees, A. & Scanlon, M.F. (2000) The effect of GH replacement on endothelial function and oxidative stress in adult growth hormone deficiency. European Journal of Endocrinology, 142, 254-262.
29. Smith, J.C., Lang, D., McEneny, J., Evans, L.M., Scanlon, M.F., Young, I. & Davies, J.S. (2002) Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency. Clinical Endocrinology, 56, 449-455.
30. al-Shoumer, K.A., Cox, K.H., Huges, C.L., Richmond, W. & Johnston, D.G. (1997) Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy. Journal of Clinical Endocrinology and Metabolism, 82, 2653-2659.
31. Serri, O., St-Jaques, P., Sartippour, M. & Renier, G. (1999) Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy. Journal of Clinical Endocrinology and Metabolism, 84, 58-63.
32. Serri, O., Li, L., Maingrette, F., Jaffry, N. & Renier, G. (2004) Enhanced lipoprotein lipase secretion and foam cell formation by macrophages of patients with growth hormone deficiency: possible contribution to increased risk of atherogenesis? Journal of Clinical Endocrinology and Metabolism, 89, 979-985.
33. Tsukahara, H., Gordienko, D.V., Tonshoff, B., Gelato, M.C. & Goligorsky, M.S. (1994) Direct demonstration of insulin like growth factor-I-induced nitric oxide production by endothelial cells. Kidney International, 45, 598-604.
34. Boger, R.H., Skamira, C., Bode-Boger, S.M., Brabant, G., von zur Muhlen, A. & Frolich, J.C. (1996) Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. Journal of Clinical Investigation, 98, 2706-2713.